Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김태형 | - |
dc.date.accessioned | 2017-11-07T04:31:59Z | - |
dc.date.available | 2017-11-07T04:31:59Z | - |
dc.date.issued | 2016-01 | - |
dc.identifier.citation | Tuberculosis and Respiratory Diseases, v. 79, NO 1, Page. 22-30 | en_US |
dc.identifier.issn | 1738-3536 | - |
dc.identifier.issn | 2005-6184 | - |
dc.identifier.uri | https://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2016.79.1.22 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11754/30525 | - |
dc.description.abstract | Background The purpose of this study was to document outcomes following withdrawal of a single inhaler (step-down) in chronic obstructive pulmonary disease (COPD) patients on triple therapy (long-acting muscarinic antagonist and a combination of long-acting β2-agonists and inhaled corticosteroid), which a common treatment strategy in clinical practice. Methods Through a retrospective observational study, COPD patients receiving triple therapy over 2 years (triple group; n=109) were compared with those who had undergone triple therapy for at least 1 year and subsequently, over 9 months, initiated inhaler withdrawal (step-down group, n=39). The index time was defined as the time of withdrawal in the stepdown group and as 1 year after the start of triple therapy in the triple group. Results Lung function at the index time was superior and the previous exacerbation frequency was lower in the stepdown group than in the triple group. Step-down resulted in aggravating disease symptoms, a reduced overall quality of life, decreasing exercise performance, and accelerated forced expiratory volume in 1 second (FEV1) decline (54.7±15.7 mL/yr vs. 10.7±7.1 mL/yr, p=0.007), but there was no observed increase in the frequency of exacerbations. Conclusion Withdrawal of a single inhaler during triple therapy in COPD patients should be conducted with caution as it may impair the exercise capacity and quality of life while accelerating FEV1 decline. | en_US |
dc.description.sponsorship | This study was supported by a grant from the Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020 and A102065). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Korean National Tuberculosis Association | en_US |
dc.subject | Pulmonary Disease | en_US |
dc.subject | Chronic Obstructive | en_US |
dc.title | Outcome of Inhaler Withdrawal in Patients eceiving Triple Therapy for COPD | en_US |
dc.type | Article | en_US |
dc.relation.no | 1 | - |
dc.relation.volume | 79 | - |
dc.identifier.doi | 10.4046/trd.2016.79.1.22 | - |
dc.relation.page | 22-30 | - |
dc.relation.journal | Tuberculosis and Respiratory Diseases | - |
dc.contributor.googleauthor | Kim, Sae Ahm | - |
dc.contributor.googleauthor | Lee, Ji-Hyun | - |
dc.contributor.googleauthor | Kim, Eun-Kyung | - |
dc.contributor.googleauthor | Kim, Tae-Hyung | - |
dc.contributor.googleauthor | Kim, Woo Jin | - |
dc.contributor.googleauthor | Lee, Jin Hwa | - |
dc.contributor.googleauthor | Yoon, Ho Il | - |
dc.contributor.googleauthor | Baek, Seunghee | - |
dc.contributor.googleauthor | Lee, Jae Seung | - |
dc.contributor.googleauthor | Oh, Yeon-Mok | - |
dc.contributor.googleauthor | Lee, Sang-Do | - |
dc.relation.code | 2016041271 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | drterry | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.